Mounjaro Dose Guide UK — 2.5mg to 15mg Explained

Mounjaro (tirzepatide) is prescribed on a carefully controlled dose schedule — starting at 2.5mg and increasing every four weeks until you reach either 15mg or the dose that delivers your target weight loss with acceptable side effects. This is not arbitrary. The titration schedule exists because your body needs time to adapt at each dose level, and the people who rush it experience significantly worse side effects without meaningfully better weight loss.

This guide covers every dose in the schedule in detail — what actually happens week by week, what weight loss to expect, how side effects change, what to eat, what supplements matter at each level, and how to make the most critical decisions: when to progress, when to hold, and what your maintenance dose looks like.

How Mounjaro titration works — and why it matters

Titration means starting at a low dose and increasing gradually over time. For Mounjaro, this means beginning at 2.5mg — a dose so low it produces minimal side effects and modest weight loss — and stepping up by 2.5mg every four weeks until you reach your target dose.

The pharmacokinetics of tirzepatide explain why 4 weeks is the minimum. Mounjaro has a half-life of approximately 5 days, meaning it takes approximately 4 weeks (4–5 half-lives) to reach steady-state plasma concentrations at each dose level. In practical terms, this means:

• The full effect of any dose is not felt until week 3–4 at that dose — not the day you inject it
• Progressing before week 4 means escalating before you have experienced the full effect of the current dose
• Side effects are typically worst in weeks 1–2 at any new dose and improve substantially by weeks 3–4 as plasma levels stabilise

Why you cannot safely start at a higher dose

Starting at 15mg from day one would produce severe, protracted nausea and vomiting that the slow titration schedule is specifically designed to prevent. The titration process allows gut GLP-1 receptors to desensitise gradually, reducing the intensity of gastrointestinal side effects. It also gives your prescriber the opportunity to identify your optimal maintenance dose — which for many people is below 15mg.

Clinical trials confirm: starting at a higher dose does not produce meaningfully better long-term outcomes. The people who reach 15mg steadily over 5 months achieve similar or better weight loss outcomes than hypothetical fast-track approaches, with substantially better tolerability and adherence.

The full Mounjaro dose schedule UK — 2.5mg to 15mg

Weight loss ranges are broad because individual response varies significantly based on starting weight, diet, exercise, and adherence to protein targets. Heavier starting weights produce higher absolute weight loss at each dose level.

2.5mg — Week 1 to 4 in detail

What week-by-week life actually looks like at 2.5mg

The most common 2.5mg mistakes

• “It’s not working” — judging too early: the scale drop in weeks 1–2 is water weight. When it slows in week 3, many people assume the medication has failed. It hasn’t — real fat loss is just beginning. Give it the full 4 weeks.
• Not starting supplements immediately: protein deficiency, electrolyte depletion, and vitamin D deficiency do not wait until you are on a higher dose. Start the full nutritional stack from day 1.
• Eating less than 1,200 calories because appetite is gone: the medication creates appetite suppression — not permission to eat almost nothing. At sub-800 calories, muscle loss accelerates and hair loss risk increases. Hit your protein minimum every day regardless of appetite.

5mg — Weeks 5 to 8: The first real test

Week-by-week at 5mg

5mg is a valid maintenance dose — for some people

SURMOUNT trial data shows average weight loss of 16% at 5mg maintenance over 72 weeks. For a 16-stone (102kg) person, this is approximately 16kg (35lbs). That is a significant outcome. Not everyone needs to push to 15mg. If 5mg produces strong appetite suppression and consistent weight loss, and side effects are well managed — discuss with your prescriber whether staying at 5mg makes sense as your maintenance dose.

7.5mg — Weeks 9 to 12: Where weight loss accelerates

What changes at 7.5mg that most people don’t expect

Food aversions become specific and strong. Many people find particular foods — often the ones they ate most frequently before the medication — become actively unappealing. Red meat, fried food, and heavy meals are commonly reported triggers for nausea at 7.5mg. This is GLP-1-mediated food aversion and is not permanent, but it is pronounced at higher doses.

The “soft food trap” becomes a real risk. When solid protein foods become unappealing, people naturally drift toward whatever is palatable — which is often ice cream, crackers, yoghurt with sugar, or other soft, lower-protein foods. This produces weight loss but poor body composition — you lose muscle alongside fat. The solution is high-protein soft foods: Greek yoghurt (0%), cottage cheese, protein shakes, scrambled eggs, tinned fish, silken tofu.

Hair loss often begins here. Telogen effluvium — the hair shedding triggered by rapid weight loss — typically begins 2–4 months after significant weight loss starts. If you started Mounjaro at an accelerated dose, 7.5mg month three is exactly when this would manifest. The most important intervention is protein and vitamin D3 — both covered by Daily Fuel.

10mg — Weeks 13 to 16: The sweet spot for most people

The 10mg vs 15mg decision — how to think about it

This is one of the most common questions at this point in the titration schedule. Here is how to think about it clearly:

Cumulative results by week 16 — what to realistically expect

12.5mg — Weeks 17 to 20: Pushing further

Why the 12.5mg → 15mg step matters less than you think

SURMOUNT-1 showed 21.4% average weight loss at 10mg and 22.5% at 15mg over 72 weeks — a 1.1 percentage point difference. At 18 stone (114kg), this represents approximately 1.25kg (2.75lbs) of additional weight loss from the entire additional dose journey. For some people that matters; for others, the increased side effect burden is not worth it. This is a decision to make with your prescriber, not an automatic default to escalate.

15mg — Week 21 onwards: Maximum dose

Long-term at 15mg — the maintenance phase

Once weight loss slows to 0.5–1lb per week or stops — typically 12–18 months in — you have reached your body’s setpoint for this dose. At this point, the medication’s role shifts from active weight loss to weight maintenance. SURMOUNT-4 showed that continuing Mounjaro at the maintenance dose prevents the weight regain that occurs when it is stopped. This is the point to have an honest conversation with your prescriber about long-term treatment strategy.

When to progress to the next dose — and when to hold

Is it OK to stay at the same dose indefinitely?

Yes — absolutely. There is no medical requirement to escalate to the maximum dose. The goal is the lowest dose that achieves your weight loss target with acceptable tolerability. Many people have excellent long-term outcomes at 5mg, 7.5mg, or 10mg. “Maintenance dose” means the dose you stay on — not the maximum available.

Missed a dose? Exactly what to do

Tirzepatide half-life is approximately 5 days — this means missing one injection does not cause immediate loss of effect. The weekly plasma level dip is small. However, consistent weekly injection at the same time maintains the most stable appetite suppression throughout the week.

Best day and time to inject

There is no medically optimal time. Choose a day and time that you will consistently remember and that minimises disruption when side effects peak (24–72 hours post-injection):

• Friday or Saturday evening injection: most popular choice — side effects peak over the weekend when work demands are lowest
• Sunday morning: good choice if weekdays are demanding — Monday-Tuesday side effects are typically lightest by this point in treatment
• Avoid Monday injection if your job requires your full concentration on Monday–Tuesday and you are still in the titration phase where side effects are more pronounced

Side effects at each dose — what to expect and manage

Nausea — the most common, and the most manageable

The most effective nausea management strategies, in order:

1. Eat slowly — minimum 20 minutes per meal. Put cutlery down between bites.
2. Stop at 70–80% full — not when the plate is empty
3. Avoid carbonated drinks completely (including sparkling water)
4. Ginger tea before and after meals — evidence-based antiemetic
5. Peppermint tea between meals
6. Cold food over hot food on bad days — cooking smells worsen nausea
7. Room-temperature injection pen (not cold from fridge)
8. Ask prescriber for ondansetron or metoclopramide for severe days

Constipation — very common, very manageable

GLP-1 receptors throughout the gut slow peristalsis — the wave of muscle contractions that moves food through. This is compounded by reduced food volume and reduced fluid intake (thirst is suppressed alongside appetite). The intervention hierarchy:

1. 2.5 litres of still water per day — scheduled, not thirst-triggered
2. 25–30g dietary fibre daily (oats, lentils, vegetables, Daily Fuel fibre)
3. Psyllium husk (1 tsp in a large glass of water before bed)
4. Probiotics — 15-strain formula to support gut motility
5. 20-minute walk after main meals directly stimulates peristalsis
6. Macrogol/Movicol (osmotic laxative) — OTC, safe for regular use if dietary measures insufficient
7. Avoid stimulant laxatives (senna) for regular use — can cause dependency

Hair loss — when it comes, what helps

Hair loss (telogen effluvium) typically begins 2–4 months after significant weight loss starts — often in the 7.5mg–10mg phase for people who started Mounjaro at the beginning. It is caused by the physiological stress of rapid weight loss, not by the medication directly. The most important interventions:

• Protein — 1.6g/kg target weight daily, every day. Hair is keratin (protein). This is the single most important intervention.
• Vitamin D3+K2 — vitamin D receptors in hair follicles; deficiency independently worsens telogen effluvium
• Iron — most important for premenopausal women; test ferritin before supplementing
• Zinc and B12 — both in Daily Fuel at 100% NRV
• Biotin Plus — additional targeted hair support alongside protein foundation
• Do not stop Mounjaro — hair loss is caused by weight loss, not the medication. Stopping restores weight (and the trigger) but the hair loss cycle continues.

Nutrition at each dose level — what changes and why

Nutritional requirements and challenges shift at each dose level. Here is what changes and what to prioritise:

The protein minimum — non-negotiable at any dose

Protein target: minimum 1.6g per kg of target body weight, every day. On the worst days, when eating feels impossible, a protein shake in 300ml of water is not optional — it is the most important thing you will eat.

Supplements at each dose — what to take and when

Plateauing at a dose — what is actually happening

Weight loss typically slows and eventually plateaus at any given dose as the body adapts. This does not mean the medication has stopped working. It means your TDEE (total daily energy expenditure) has decreased as your body weight has decreased — the same food intake that previously created a deficit may now be at or near maintenance.

Escalating the dose to break a plateau without addressing the above is a common mistake. The higher dose will provide temporary additional weight loss, but if the underlying causes (dietary drift, insufficient protein, reduced TDEE) are not addressed, you will plateau again at the higher dose — having used up dose headroom unnecessarily.

Finding your maintenance dose

Your maintenance dose is the lowest dose at which you achieve your weight loss target with acceptable tolerability. It is not automatically 15mg.

Signs you have found your maintenance dose:

• Weight loss has slowed to <0.5lbs per week at this dose with all nutritional factors optimised
• Side effects are well managed and stable
• Appetite suppression feels consistent and liveable for the long term
• You are at or approaching your target weight

At this point, the conversation with your prescriber shifts from “when do I increase?” to “how long do I maintain?” SURMOUNT-4 data shows that continuing treatment prevents the significant weight regain that follows stopping. Long-term Mounjaro use is medically safe and appropriate for obesity management.

What happens when you stop Mounjaro — and how to minimise it

SURMOUNT-4 — the trial that specifically studied what happens after stopping tirzepatide — is the most important piece of data for planning Mounjaro treatment duration:

This data does not mean Mounjaro is not worth taking — it clearly is. It means that weight management is a long-term condition, not a short-term treatment. The medication addresses the biological mechanisms that cause obesity. When it is removed, those mechanisms reassert.

How to minimise regain if stopping is necessary

• Discuss structured tapering with your prescriber — stepping down slowly (15mg → 12.5mg → 10mg → etc.) over several months may moderate the appetite rebound compared to abrupt stopping
• Increase protein intake further when tapering — protein is the primary non-medication tool for hunger management
• Maintain the habits built during treatment — the medication period is the ideal time to genuinely establish the eating patterns and exercise habits that will continue to work without it
• Continue supplements — Daily Fuel, Triple Magnesium, Electrolytes, and Vitamin D3+K2 remain relevant after stopping
• Increase exercise — physical activity is the most reliable substitute for appetite suppression effects

Complete FAQ — 40+ questions answered

The week-by-week experience — a realistic account

Most Mounjaro guides tell you what the titration schedule is. Very few tell you what the experience actually feels like week by week. Here is an honest account based on what the research and clinical experience shows:

Weeks 1–4 (2.5mg): “Is this doing anything?”

The most common experience at 2.5mg is mild surprise that the effects are subtle. People who start Mounjaro expecting immediate dramatic appetite suppression are frequently disappointed at this dose. This is by design. The starting dose is for your body to establish a baseline response to the medication, not to produce the full therapeutic effect. The scale drop in week 1 (2–5lbs for most) feels promising, then slows in weeks 2–3, and many people worry the medication has stopped working. It hasn’t — the water weight has simply come off and real fat loss is beginning.

The best thing you can do at 2.5mg is use the relatively easy adjustment period to establish the habits that will matter enormously at higher doses: daily protein shake, electrolytes, vitamin D, consistent sleep time. Building the supplement and nutrition routine when side effects are minimal means it is automatic by the time the medication gets harder to manage.

Weeks 5–8 (5mg): “OK, now I feel it”

5mg is where most people first genuinely feel the medication changing their relationship with food. Food becomes less interesting. The usual afternoon hunger at 3pm simply does not arrive. Meals feel satisfying at smaller portions. Many people describe this as the most encouraging phase — visible results combined with the first real experience of reduced food noise.

It is also where the first significant nausea often occurs. Eating a large meal, eating too fast, or drinking a fizzy drink can produce 2–4 hours of uncomfortable nausea at 5mg. The learning curve around eating pace and portion size is steepest here. Most people who struggle with Mounjaro either learn these lessons here — or abandon the medication here without understanding that their side effects were behavioural and preventable.

Weeks 9–12 (7.5mg): “This is serious now”

7.5mg is where the medication crosses from “noticeable” to “significant”. Food aversions become specific — many people find previously enjoyed meals suddenly unappealing. The smell of certain cooking processes (particularly meat, frying) can trigger nausea. This is uncomfortable but temporary.

This is also the first phase where nutritional consequences become a real clinical concern. Hair loss may begin (2–4 months after significant weight loss started). Energy may drop if electrolytes are not managed. Sleep quality may be disrupted. The people who are supplementing properly sail through this phase with manageable side effects; the people who are not supplementing experience symptoms that feel like medication problems but are actually nutrition problems.

Weeks 13–16 (10mg): “Finding a rhythm”

By 10mg, the titration schedule has run for three months. Most people who have made it to 10mg through proper titration find this dose is where they develop a stable routine. The eating habits around the medication are established. They know their injection day timing, their protein routine, their supplement stack. The weekly rhythm becomes predictable.

This is also the point where the first plateau often appears — not because the medication has failed, but because the body has adapted its TDEE to the reduced calorie intake. The intervention is straightforward: recalculate your calorie target at current weight (not starting weight), audit protein, and ensure you are still in a genuine deficit. Most 10mg plateaus resolve within 2–4 weeks of this recalibration.

Weeks 17+ (12.5mg–15mg): “Maintenance territory”

Higher doses often produce a paradox: the medication is at its most powerful in terms of appetite suppression, but the practical experience of daily life can feel more effortful, not less. Eating feels like a chore. Food that was previously enjoyable is now neutral or aversive. The psychological relationship with food has changed profoundly.

Some people find this liberating — food no longer controls them. Others find the changed relationship with eating difficult in social contexts, family settings, and celebratory occasions. Neither response is wrong. Both deserve honest conversation with your prescriber and, if needed, with a therapist who understands weight management.

Mounjaro and Type 2 Diabetes — how dosing differs

Mounjaro was originally licensed in the UK for Type 2 diabetes management. The dosing schedule is the same whether prescribed for diabetes or weight management, but the maintenance dose target differs:

People with Type 2 diabetes on Mounjaro may find their blood sugar management improves dramatically before they reach higher weight loss doses — and their prescriber may be more cautious about rapid escalation if glycaemic control is already excellent. Blood glucose monitoring is important throughout treatment for Type 2 diabetes patients, particularly when also taking sulfonylureas or insulin (which may need dose reduction as tirzepatide improves insulin sensitivity).

Mounjaro and contraception — what you need to know

GLP-1 medications delay gastric emptying, which affects the absorption of oral contraceptives. Research by Skelley et al. (2024) in the Journal of the American Pharmacists Association found that tirzepatide significantly reduced the absorption of ethinylestradiol and levonorgestrel (the hormones in combined oral contraceptives) by approximately 25–35%.

The practical implication: oral contraceptive pills may be less effective while taking Mounjaro, particularly in the first 4 weeks of any new dose level when gastric slowing is at its most pronounced. The most cautious approach is to use a non-oral contraceptive method (IUD, implant, injection, patch, condom) throughout Mounjaro treatment. Discuss with your GP or prescriber — the risk level depends on the specific oral contraceptive formulation and your individual absorption response.

Drug interactions — what to watch for

Mounjaro has a relatively clean interaction profile for a weekly injection. Key interactions to be aware of:

Monitoring your health during Mounjaro treatment

Most UK private prescribers require regular monitoring consultations throughout Mounjaro treatment. What should be monitored, and why:

When to contact your prescriber between scheduled appointments

Most Mounjaro side effects are manageable at home. Contact your prescriber or GP without waiting for a scheduled appointment if you experience:

• Severe or persistent abdominal pain, especially upper-middle abdomen radiating to the back — possible pancreatitis, which is rare but serious
• Persistent vomiting — unable to keep any fluid or food down for more than 24 hours; dehydration risk
• Signs of severe dehydration — very dark or no urine output, rapid heartbeat, confusion
• Vision changes — blurred vision or any sudden change in vision
• Severe mood changes or thoughts of self-harm
• Signs of allergic reaction — rash, swelling, breathing difficulty
• Lump or swelling in the neck — thyroid-related concerns (rare)

Mounjaro and the psychological side — what many guides skip

The physical changes from Mounjaro are well documented. The psychological changes receive less attention — but they are equally significant and deserve honest discussion.

The “food noise” reduction

Many people describe the most profound effect of GLP-1 medication as not the appetite reduction per se, but the reduction in “food noise” — the constant background mental chatter about food, cravings, planning what to eat next, thinking about food between meals. For people who have struggled with food thoughts for years, this reduction is described as life-changing. For others, the absence of a previously central aspect of daily experience feels unsettling. Both responses are valid and worth discussing with your clinical team.

Identity and social eating

Food is deeply social. When you cannot eat at a restaurant, struggle to finish a meal at a dinner party, or find previously enjoyed foods unappealing — the social consequences can be significant. Explaining GLP-1 medication to family and friends, navigating social expectations around eating, and maintaining relationships that have food at their centre requires thought and communication that most dose guides do not address.

When weight loss brings up unexpected emotions

Significant weight loss changes how you look, how you move, how people treat you, and how you see yourself. These changes are not universally comfortable even when the physical changes are positive. Some people experience grief for the version of themselves that struggled; others experience anxiety about maintaining the changes; others find that previously attributed internal qualities (comfort, self-sabotage) were partly physiological (insulin resistance, leptin resistance) rather than character flaws — and need to reconcile this. These are real, common, and underserved aspects of Mounjaro treatment.

The research — what SURMOUNT actually showed

The SURMOUNT clinical trial programme was the definitive evidence base for tirzepatide in obesity. Key findings relevant to dosing decisions:

SURMOUNT-1 (2022, N=2,539, 72 weeks):

• 5mg: mean weight change -16.0% vs -2.4% placebo
• 10mg: mean weight change -21.4% vs -2.4% placebo
• 15mg: mean weight change -22.5% vs -2.4% placebo
• Participants achieving ≥20% body weight reduction: 5mg = 39%, 10mg = 49%, 15mg = 57%

SURMOUNT-2 (2023, Type 2 diabetes, N=938, 72 weeks):

• 10mg: mean weight change -13.4%
• 15mg: mean weight change -15.7%
• Slightly lower weight loss than SURMOUNT-1 (non-diabetes population) — consistent with T2DM pharmacology

SURMOUNT-4 (2023, withdrawal study, N=783):

• 52-week withdrawal phase: average weight regain of ~14% of body weight within 52 weeks of stopping
• Continuing tirzepatide: further weight loss of 5.5% vs baseline during the 52-week extension
• Confirms: weight management is chronic; medication continuation prevents regain

SURMOUNT-MMO head-to-head vs semaglutide (2024):

• Tirzepatide produced significantly greater weight loss than semaglutide 2.4mg at 52 weeks
• Confirmed the clinical superiority of the dual GIP/GLP-1 mechanism for weight management

Quick reference — the complete Mounjaro dose schedule at a glance

📋 Download the free 14-day meal plan — designed for GLP-1 users at every dose level.

Related: How to Lose Weight on Mounjaro UK | Best Supplements on Mounjaro UK | GLP-1 Side Effects UK | What to Eat on Mounjaro UK | Hair Loss on Mounjaro UK | Mounjaro Plateau UK